Another ramification of this study is that our findings on Smurf2‐mediated proteolysis of progerin lay a foundation for evaluating the efficiency of progerin clearance by Smurf2 as a possible therapeutic approach in progeria treatment. This evidence concerns the gene SMURF2 and progeroid syndrome.